Literature DB >> 31506756

[Most important contact allergens in hand eczema].

V Mahler1,2, H Dickel3.   

Abstract

The head and hands are the two most common locations for allergic contact dermatitis manifestation. In hand eczema, contact with a contact allergen is a frequent (co-)factor in the triggering and maintenance of eczema. For all hand eczemas lasting longer than 3 months, an allergological examination by means of patch testing is recommended. In patients with allergic contact dermatitis of the hands, nickel, MCI/MI, fragrance mix I, cobalt, thiuram mix, Balsam of Peru, chromium and fragrance mix II have been described in a multicenter European study as the most common contact allergens of the standard series. In the information network of dermatological clinics (IVDK) a total of 56,170 patients were patch-tested in the years 2014 to 2018. In all, 16,807 of these patients (29.9%) suffered from hand eczema, of which 7725 (46.0%) had occupational dermatosis (OD) and 6820 (40.6%) had no OD. For the remaining patients this was unknown. The top 30-list of allergens in hand eczema patients without and with OD included 22 common contact allergens, but with different reaction frequency. In hand eczema patients without OD, the following contact allergens also belong to this list: octyl gallate, sorbic acid, tert-butylhydroquinone, propylene glycol, mercury (II) amide chloride, tolubalsam, jasmine absolute, and sandalwood oil. For hand eczema patients with OD, these are instead: tetramethylthiurammonosulfide, tetramethylthiuramdisulfide, 1,3-diphenylguanidine, p‑phenylenediamine, p‑toluylenediamine, iodopropinylbutylcarbamate, glutaraldehyde, and monoethanolamine. In the case of OD of the hands, early involvement of the responsible statutory accident insurance by initiating the dermatologist procedure ("Hautarztverfahren") is necessary in order to work together towards successful allergen avoidance by means of substitution and optimizing personal protective equiment.

Entities:  

Keywords:  Allergen avoidance; Allergen top charts; Dermatologist procedure; Occupational dermatosis; Patch tests

Mesh:

Substances:

Year:  2019        PMID: 31506756     DOI: 10.1007/s00105-019-04472-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  19 in total

1.  First results from the multicentre study rehabilitation of occupational skin diseases--optimization and quality assurance of inpatient management (ROQ).

Authors:  Christoph Skudlik; Elke Weisshaar; Reginald Scheidt; Peter Elsner; Britta Wulfhorst; Michael Schönfeld; Swen Malte John; Thomas Ludwig Diepgen
Journal:  Contact Dermatitis       Date:  2011-11-09       Impact factor: 6.600

2.  Early secondary prevention of occupational skin disease in Germany: the dermatologist's procedure in perspective.

Authors:  H Dickel; O Kuss; S M John; O Blome; K H Hagemann; H J Schwanitz
Journal:  Int Arch Occup Environ Health       Date:  2003-11-13       Impact factor: 3.015

3.  Characteristics and provision of care in patients with chronic hand eczema: updated data from the CARPE registry.

Authors:  Christian Apfelbacher; Sonja Molin; Elke Weisshaar; Andrea Bauer; Peter Elsner; Vera Mahler; Melanie Weiss; Thomas Ruzicka; Thomas L Diepgen
Journal:  Acta Derm Venereol       Date:  2014-03       Impact factor: 4.437

Review 4.  [Allergological diagnostics and current allergens in occupational dermatology].

Authors:  J Geier; A Krautheim; H Lessmann
Journal:  Hautarzt       Date:  2009-09       Impact factor: 0.751

5.  European Society of Contact Dermatitis guideline for diagnostic patch testing - recommendations on best practice.

Authors:  Jeanne D Johansen; Kristiina Aalto-Korte; Tove Agner; Klaus E Andersen; Andreas Bircher; Magnus Bruze; Alicia Cannavó; Ana Giménez-Arnau; Margarida Gonçalo; An Goossens; Swen M John; Carola Lidén; Magnus Lindberg; Vera Mahler; Mihály Matura; Thomas Rustemeyer; Jørgen Serup; Radoslaw Spiewak; Jacob P Thyssen; Martine Vigan; Ian R White; Mark Wilkinson; Wolfgang Uter
Journal:  Contact Dermatitis       Date:  2015-07-14       Impact factor: 6.600

6.  Current trends in patch testing - new data from the German Contact Dermatitis Research Group (DKG) and the Information Network of Departments of Dermatology (IVDK).

Authors:  Vera Mahler; Johannes Geier; Axel Schnuch
Journal:  J Dtsch Dermatol Ges       Date:  2014-07       Impact factor: 5.584

7.  Guidelines for diagnosis, prevention and treatment of hand eczema--short version.

Authors:  Thomas L Diepgen; Klaus E Andersen; Oliver Chosidow; Peter Jan Coenraads; Peter Elsner; John English; Manigé Fartasch; Ana Gimenez-Arnau; Rosemary Nixon; Denis Sasseville; Tove Agner
Journal:  J Dtsch Dermatol Ges       Date:  2015-01       Impact factor: 5.584

8.  Patch test results of the European baseline series among patients with occupational contact dermatitis across Europe - analyses of the European Surveillance System on Contact Allergy network, 2002-2010.

Authors:  Maria Pesonen; Riitta Jolanki; Francesca Larese Filon; Mark Wilkinson; Beata Kręcisz; Marta Kieć-Świerczyńska; Andrea Bauer; Vera Mahler; Swen M John; Axel Schnuch; Wolfgang Uter
Journal:  Contact Dermatitis       Date:  2015-01-12       Impact factor: 6.600

9.  Thoughts on sensitizers in a standard patch test series. The European Society of Contact Dermatitis.

Authors:  M Bruze; L Condé-Salazar; A Goossens; L Kanerva; I R White
Journal:  Contact Dermatitis       Date:  1999-11       Impact factor: 6.600

Review 10.  The epidemiology of hand eczema in the general population--prevalence and main findings.

Authors:  Jacob P Thyssen; Jeanne D Johansen; Allan Linneberg; Torkil Menné
Journal:  Contact Dermatitis       Date:  2010-02       Impact factor: 6.600

View more
  2 in total

Review 1.  [New allergens for occupational dermatology?]

Authors:  Vera Mahler
Journal:  Hautarzt       Date:  2021-05-05       Impact factor: 0.751

2.  [Occupational dermatology-more relevant than ever].

Authors:  Elke Weisshaar; Swen Malte John
Journal:  Hautarzt       Date:  2021-06-01       Impact factor: 0.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.